Podcasts:IDIS-Ins and Outs of Comparator Sourcing
Ins and Outs of Comparator Sourcing
Sponsored by IDIS
Comparator Drug Sourcing – The Benefits of Taking a Strategic Approach
Mark Ware, Director, Clinical Trial Services at IDIS, explains how procurement teams charged with sourcing comparator drugs for clinical trials can move from a tactical sourcing approach to a strategic approach.
10 Ways to Reduce the Risk of Comparator Drug Sourcing
David Regan, Procurement Manager at IDIS, discusses the 10 ways to reduce the risks associated with sourcing comparator drugs.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
